Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: I wonder if PDSG has continued

to reduce SG&A costs:

Selling, general and administrative expenses decreased from approximately $824,000 for the three months ended February 28, 2009, to approximately $479,000 for the three months ended February 28, 2010, primarily due to management’s restructuring plan to reduce personnel and operating costs

Only one month to wait until the 10-K for actual confirmation of the factual results.

.

.

.

Be well

Share
New Message
Please login to post a reply